Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome

Mirjam Kool, V Petrilli, T De Smedt, A Rolaz, H (Hamida) Hammad, Menno van Nimwegen, Ingrid Bergen, R Castillo, Bart Lambrecht, J Tschopp

Research output: Contribution to journalArticleAcademicpeer-review

469 Citations (Scopus)

Abstract

Adjuvants are vaccine additives that stimulate the immune system without having any specific antigenic effect of itself. In this study we show that alum adjuvant induces the release of IL-1 beta from macrophages and dendritic cells and that this is abrogated in cells lacking various NALP3 inflammasome components. The NALP3 inflammasome is also required in vivo for the innate immune response to OVA in alum. The early production of IL-1 beta and the influx of inflammatory cells into the peritoneal cavity is strongly reduced in NALP3-deficient mice. The activation of adaptive cellular immunity to OVA-alum is initiated by monocytic dendritic cell precursors that induce the expansion of Ag-specific T cells in a NALP3-dependent way. We propose that, in addition to TLR stimulators, agonists of the NALP3 inflammasome should also be considered as vaccine adjuvants.
Original languageUndefined/Unknown
Pages (from-to)3755-3759
Number of pages5
JournalJournal of Immunology
Volume181
Issue number6
Publication statusPublished - 2008

Cite this